Intervention Review

Phosphodiesterase III inhibitors for heart failure

  1. Emmanuel Amsallem1,
  2. Christelle Kasparian2,
  3. G Haddour3,
  4. Jean-Pierre Boissel4,
  5. Patrice Nony5,*

Editorial Group: Cochrane Heart Group

Published Online: 24 JAN 2005

DOI: 10.1002/14651858.CD002230.pub2


How to Cite

Amsallem E, Kasparian C, Haddour G, Boissel JP, Nony P. Phosphodiesterase III inhibitors for heart failure. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD002230. DOI: 10.1002/14651858.CD002230.pub2.

Author Information

  1. 1

    CETAF, Quality - Evaluation - Etudes, Saint-Etienne Cedex 02, France

  2. 2

    APRET/EZUS, Clinical Pharmacology Unit (EA 3736), Lyon, France

  3. 3

    Hospices Civils de Lyon, Cardiovscular Hospital Louis Pradel, Lyon, France

  4. 4

    Hopital Cardio-Vasculaire et Pneumologique Louis Pradel, Centre d'Investigation Clinique - CIC de Lyon, Bron, CEDEX, France

  5. 5

    Hopital Neurocardiologique, Lyon, France

*Patrice Nony, Hopital Neurocardiologique, 28 avenue Doyen Lepine, Lyon, 69003, France. pn@upcl.univ-lyon1.fr.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 24 JAN 2005

SEARCH

  1. Current Version

    Phosphodiesterase III inhibitors for heart failure

    Emmanuel Amsallem, Christelle Kasparian, G Haddour, Jean-Pierre Boissel and Patrice Nony

    Version of Record online: 24 JAN 2005 | DOI: 10.1002/14651858.CD002230.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Phosphodiesterase III inhibitors for heart failure

    Patrice P Nony and Francoise F Martin

    Version of Record online: 24 JUL 2000 | DOI: 10.1002/14651858.CD002230